4//SEC Filing
Taveras Arthur 4
Accession 0001628280-20-016956
CIK 0001501697other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 5:28 PM ET
Size
5.6 KB
Accession
0001628280-20-016956
Insider Transaction Report
Form 4
Taveras Arthur
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-11-30$6.60/sh+121,150$799,590→ 121,150 totalExercise: $6.60Exp: 2030-11-29→ Common Stock (121,150 underlying)
Footnotes (1)
- [F1]25% of the shares subject tot he option shall vest on November 30, 2021, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001830901
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 5:28 PM ET
- Size
- 5.6 KB